Dear Editor, It is well known that some classes of neuropsychiatric drugs can cause secondary movement disorders. The class of drugs that is primarily associated with these adverse effects is the antipsychotics, but some antiepileptics and antidepressants, especially the selective serotonin recapture inhibitors, are also able to cause extrapyramidal syndromes.
Extrapyramidal symptoms (particularly tardive dyskinesia, akathisia, and Parkinsonism) induced by imipramine and other tricyclic antidepressants have already been described, 2 but there is no report of dystonia with imipramine. Although drug-induced dystonia is a common adverse reaction to other classes of drugs, including some antidepressants, this side effect is rare with tricyclic antidepressants, possibly due to its intrinsic anticholinergic action. Thus, the pharmacodynamic explanation for this idiosyncratic reaction is unclear, but unknown genetic factors 3 most likely played an important role in this case. One possible explanation that has been proposed to describe other rare cases of drug-induced dystonia 4 is the contamination of the drug with other substances during manufacturing. This seems plausible, as Brazilian public health services purchase drugs that are either produced locally or imported from industries with different levels of manufacturing practices and quality control, and contamination can occur.
Physicians must be highly suspicious when psychiatric symptoms co-occur with movement disorders, and other primary diseases must be excluded. 5 Additionally, this case report emphasizes the relevance of considering movement disorders as a possible side effect of tricyclic antidepressants, although the pharmacodynamic mechanism for this reaction is still unclear.
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